Activities per year
Activities
- 1 - 50 out of 79 results
Search results
-
Longitudinal changes in inflammatory biomarkers in early coronary artery calcification after breast cancer radiotherapy: the BACCARAT cohort study
Locquet, M. (Speaker), Jimenez, G. (Speaker), Ferrières, J. (Speaker), Lapeyre, M. (Speaker), Allodji S., R. (Speaker), Honaryar, M. K. (Speaker), Camilleri, J. (Speaker), Broggio, D. (Speaker), de Vathaire, F. (Speaker), Fabien, M. (Speaker) & Jacob, S. (Speaker)
2 May 2025 → 6 May 2025Activity: Talk or presentation types › Oral presentation
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
2 May 2025 → 6 May 2025Activity: Talk or presentation types › Oral presentation
-
Evaluation of the pragmatism of clinical trials in sarcopenia: a systematic review
Van Heden, S. (Speaker)
12 Apr 2025Activity: Talk or presentation types › Oral presentation
-
Towards a Core Outcome Set (COS) for Sarcopenia Intervention Studies: A Systematic Review identifying the most reported outcomes across randomized controlled trials in sarcopenia
Van Heden, S. (Speaker)
14 Mar 2025Activity: Talk or presentation types › Oral presentation
-
An in vitro cell based model for testing NETosis inhibitors and proNETotic agents.
Michaux, P. (Speaker), Bouarroudj, H. (Speaker) & Douxfils, J. (Speaker)
27 Mar 2025Activity: Talk or presentation types › Oral presentation
-
The Great Influenza! (La Grande Grippe)
Absil, S. (Speaker)
28 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Reduced Risk of Venous Thromboembolism with Natural Estrogen-Based COCs Compared to Ethinylestradiol Pills
Raskin, L. (Speaker)
27 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Effect of E4/DRSP 15/3 mg on Hemostasis Parameters in Post-Menarchal Adolescents: A Phase 3 Multicentre Study
Douxfils, J. (Speaker)
20 Mar 2025Activity: Talk or presentation types › Oral presentation
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker), Jacob, S. (Speaker), Geets, X. (Speaker) & Beaudart, C. (Speaker)
13 Feb 2025Activity: Talk or presentation types › Oral presentation
-
Histoire du lien entre consommation de psychotropes et création artistique
Absil, S. (Speaker)
7 Feb 2025Activity: Talk or presentation types › Oral presentation
-
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Locquet, M. (Speaker)
13 Feb 2025Activity: Talk or presentation types › Oral presentation
-
Towards developing a core outcome set for Osteosarcopenia intervention studies
Van Heden, S. (Speaker)
18 Jan 2025Activity: Talk or presentation types › Oral presentation
-
Les médecins généralistes face à l'hésitation vaccinale contre le Covid-19.
Absil, S. (Speaker)
16 Nov 2024Activity: Talk or presentation types › Oral presentation
-
The Great Influenza ! (La grande grippe)
Absil, S. (Speaker)
15 Nov 2024Activity: Talk or presentation types › Oral presentation
-
EuroThrombosis & Eurovessels 2024 - Asundexian and milvexian: What impact on the activity of the intrinsic pathway ?
Vassart, J. (Speaker)
12 Oct 2024Activity: Talk or presentation types › Oral presentation
-
Histoire de l'enseignement de la médecine en Belgique
Absil, S. (Speaker)
15 Jun 2024Activity: Talk or presentation types › Oral presentation
-
Impact de l'estetrol sur la coagulation chez les femmes ménopausées
Didembourg, M. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Differentiated thyroid cancers risks in French Polynesia: Role of Nuclear tests’
Locquet, M. (Speaker)
7 Mar 2024Activity: Talk or presentation types › Oral presentation
-
13ème symposium annuel du Namur Thrombosis and Hemostasis Center (NTHC) - Présentation de "Impact of FXI inhibitors on coagulation testing"
Vassart, J. (Speaker)
28 Mar 2024Activity: Talk or presentation types › Oral presentation
-
17e Congrès de la Médecine Générale France (CMGF 2024)
Absil, S. (Speaker)
21 Mar 2024Activity: Talk or presentation types › Oral presentation
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Navigating new regulations in biobanking for clinical studies and research projects
Douxfils, J. (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
Aspirin and non-aspirin antiplatelet agents use and risk of ischemic and hemorrhagic stroke in patients with non-valvular atrial fibrillation with and without anticoagulant therapy: a case-referent study
Grimaldi, L. (Speaker), Hamon, Y. (Speaker), Locquet, M. (Speaker), Benichou, J. (Speaker) & Abenhaim, L. (Speaker)
Aug 2023Activity: Talk or presentation types › Oral presentation
-
Reconstruction d'épiderme en milieu animal-free
Poumay, Y. (Speaker)
16 Jun 2023Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Douxfils, J. (Invited speaker) & Foidart, J.-M. (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Prediction Of Venous Thromboembolism Risk Associated With Combined Oral Contraceptives: An Exploratory Model
Morimont, L. (Speaker)
19 May 2023Activity: Talk or presentation types › Oral presentation
-
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Morimont, L. (Speaker)
27 Apr 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Douxfils, J. (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Protective effects of medications on cardiovascular events in systemic lupus erythematosus in real-life: a systematic new-user cohort study
Duchemin , T. (Speaker), Hamon, Y. (Speaker), Abenhaim, L. (Speaker), Benichou, J. (Speaker), Locquet, M. (Speaker), Buchard, A. (Speaker), Moride, Y. (Speaker) & Grimaldi, L. (Speaker)
2023Activity: Talk or presentation types › Oral presentation
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Low thrombin generation in menopausal women using Estetrol (E4)
Morimont, L. (Speaker)
27 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Affinity Capillary Electrophoresis in Fragment-Based Drug Discovery Projects, a Tool for Hit Discovery and Binding Site Characterization
DAVOINE, C. (Speaker)
4 Jul 2022Activity: Talk or presentation types › Oral presentation
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Douxfils, J. (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker) & Douxfils, J. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Thérapie hormonale et thromboembolie veineuse – Rôle et évaluation de la résistance à la protéine C activée
Morimont, L. (Speaker)
17 May 2022Activity: Talk or presentation types › Oral presentation
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Morimont, L. (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Combined oral contraceptives (COC) and venous thromboembolism (VTE): role and evaluation of activated protein C resistance
Morimont, L. (Speaker)
28 Apr 2022Activity: Talk or presentation types › Oral presentation
-
Evènements cardiovasculaires occlusifs associés aux inhibiteurs de tyrosine kinase ciblant BCR-ABL: Identification, compréhension et prédiction.
Haguet, H. (Speaker)
11 Feb 2022Activity: Talk or presentation types › Oral presentation
-
Assessment of the thrombotic risk associated with IVF treatment
Morimont, L. (Speaker)
10 Sept 2021Activity: Talk or presentation types › Oral presentation
-
Early subclinical cardiovascular changes after radiotherapy detected by echocardiography in women with breast cancer: contribution of the MEDIRAD EARLY-HEART cohort
Locquet, M. (Speaker)
2021Activity: Talk or presentation types › Oral presentation
-
Short term decline in muscle function is associated with mortality in the SarcoPhAge study
Locquet, M. (Speaker)
2020Activity: Talk or presentation types › Oral presentation
-
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Douxfils, J. (Invited speaker)
9 Jul 2019Activity: Talk or presentation types › Oral presentation
-
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Douxfils, J. (Invited speaker)
20 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Douxfils, J. (Invited speaker)
14 Jun 2019Activity: Talk or presentation types › Oral presentation
-
Affections thromboemboliques veineuses – partie II
Douxfils, J. (Keynote speaker)
12 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Bone health assessment in older people with or without muscle health impairment
Locquet, M. (Speaker)
2019Activity: Talk or presentation types › Oral presentation
-
Belgian College of Neuropsychopharmacology and Biological Psychiatry, annual symposium
Desseilles, M. (Speaker)
14 Dec 2018Activity: Talk or presentation types › Oral presentation
-
Interference of DOACs in coagulation tests
Douxfils, J. (Invited speaker)
9 Nov 2018Activity: Talk or presentation types › Oral presentation
-
Educational I - Should we measure DOACs?
Douxfils, J. (Invited speaker)
22 Nov 2018Activity: Talk or presentation types › Oral presentation